Recruitment

Recruitment Status
Completed
Estimated Enrollment
600

Inclusion Criterias

Stationary patients undergoing lymph node resection.
Stationary patients undergoing lymph node resection.

Exclusion Criterias

Contraindications, such as hypersensitivity to the active pharmaceutical ingredient or to another ingredient.
Contraindications, such as hypersensitivity to the active pharmaceutical ingredient or to another ingredient.

Summary

Conditions
Lymph Node Resection
Type
Observational
Design
  • Observational Model: Cohort
  • Time Perspective: Prospective

Participation Requirements

Age
Between 18 years and 125 years
Gender
Both males and females

Description

The aim of this non-interventional study (NIS) was to collect further knowledge on the routine use of TachoSil ® in lymph node surgery where its sealing property helps to reduce the rate of postoperative complications, especially of seroma formation. Some data are already available from gynecology, ...

The aim of this non-interventional study (NIS) was to collect further knowledge on the routine use of TachoSil ® in lymph node surgery where its sealing property helps to reduce the rate of postoperative complications, especially of seroma formation. Some data are already available from gynecology, urology and thoracic surgery.

Inclusion Criterias

Stationary patients undergoing lymph node resection.
Stationary patients undergoing lymph node resection.

Exclusion Criterias

Contraindications, such as hypersensitivity to the active pharmaceutical ingredient or to another ingredient.
Contraindications, such as hypersensitivity to the active pharmaceutical ingredient or to another ingredient.

Locations

Greifswald
Greifswald

Tracking Information

NCT #
NCT01920958
Collaborators
Not Provided
Investigators
Study Director: Medical Director Takeda Pharma Vertrieb GmbH & Co. KG